The gut microbiota modulates the onset and progression of post-stroke neuroinflammation through multidimensional mechanisms via the “immune-neuro-endocrine” feedback pathway at multiple levels at multiple levels.
Abstract
Stroke is a complex and highly heterogeneous acute cerebrovascular disease characterized by high incidence, disability rates, and mortality. The occurrence of a stroke is the result of a series of chain reactions. Neuroinflammation, as a core component of the pathological process of stroke, serves as the dynamic hub of this chain of reactions. It acts both as a driving force in disease progression and a key regulator of functional recovery. Increasing evidence indicates that the gut microbiota has a dynamic coupling relationship with the neuroinflammatory pathological processes involved in stroke. This review aimed to explore the mechanisms by which the gut microbiota influences neuroinflammation following stroke and to evaluate its therapeutic potential in stroke. Following a stroke, up to 50% of patients have pathophysiological changes in the gastrointestinal tract, which are closely associated with delayed recovery, increased mortality, and worsened neurological outcomes. The gut microbiota can modulate post-stroke neuroinflammation through multiple pathways, including immune regulation (innate and adaptive immunity), neural signal transmission (vagus nerve and enteric nervous system), neuroendocrine transmission (hypothalamus-pituitary-adrenal axis), and gut microbiota metabolite pathways. This “central-peripheral-central” feedback loop is considered a potential intervention target. In this review, we summarized the characteristics of gut microbiota alterations following stroke, elucidated its mechanisms of action in neuroinflammation, and explored gut microbiota-based intervention strategies and their limitations. Finally, we proposed directions to provide new insights and references for clinical translation for the prevention and treatment of stroke. The gut microbiota plays a key role in post-stroke pathology. The gut microbiota modulates the onset and progression of post-stroke neuroinflammation through multidimensional mechanisms via the “immune-neuro-endocrine” feedback pathway at multiple levels. Interventions targeting the gut microbiota can not only suppress excessive inflammation but also repair neural networks, ultimately improving functional outcomes after stroke.
BACKGROUND AND PURPOSE
Ischemic stroke (IS) remains a leading global cause of mortality and disability. Although current reperfusion strategies have advanced, the complex pathological mechanisms underlying IS continue to significantly limit clinical prognosis. Recently, the pivotal role of the microbiota-gut-brain axis...
Zhengyuan Liu, Xin-Wei Zhao, Ze-Yu Yang et al.· Journal of Stroke & Cerebrov...· 0 citations
Highlights What are the main findings? Ischemic stroke is accompanied by elevated LPS levels in the gut, circulation, and brain. Changes in gut Verrucomicrobiota abundance are spatially associated with increased LPS immunoreactivity in the ischemic brain. What are the implications of the main findings? These findings r...
Ke-Min Li, Wan-Cong Ding, Shuang Wang et al.· Cells· 0 citations
Interventions discussed in this review are presented not as clinical recommendations for the general population, but as potential translational targets requiring validation in clearly defined VaD or vascular cognitive impairment subgroups.
Süheyla Ünal· Academia Neuroscience and Br...· 0 citations
A better understanding of the GM-miRNA axis may facilitate the development of novel biomarkers and personalized therapeutic strategies, ultimately shifting MS management from symptomatic treatment toward precision, disease-modifying interventions.
Farzaneh Rafie Sedaghat, A. Hasani, V. Poortahmasebi et al.· Folia Microbiologica (Prague...· 0 citations
This review synthesizes recent advances in understanding how peripheral immunity and gut microbiota influence neurodegenerative processes, highlighting key signaling pathways and mechanisms and examines current therapeutic strategies.
Vishwadeep Singh, V. Saxena, Sanskriti Upadhyay· Journal of Human Nutrition a...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.